AstraZeneca Pharma India Ltd. (ASTRAZEN)
Market Closed
15 Oct, 10:00 PM
MSE XNSE Primary MSE ₹
5,922. 60
-20.9
-0.3516%
₹
- Market Cap
- P/E Ratio
96% Div Yield
292 Volume
- Eps
₹ 5,943.5
Previous Close Want to track ASTRAZEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AstraZeneca Pharma India Ltd. (ASTRAZEN) Statistics
Valuation metrics
Market Cap -
Enterprise value 145.93B
Trailing P/E (ttm) 86.03
Forward P/E -
PEG ratio -11.49
Price/Sales (ttm) 6
Price/Book (mrq) 16.72
Enterprise Value/Revenue 6
Enterprise Value/EBITDA 60.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 675
Average volume (90 days) 583
Price summary
52-Week low 5,660
52-Week high 9,850
Beta -
50-Day moving average 6,653.84
200-Day moving average 7,870.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 36
Trailing annual dividend yield 0.0062%
5-Year annual dividend yield -
Payout ratio 0.47
Dividend Date 8 Sep 2026
Ex-Dividend Date 31 Jul 2026
Last split factor 5:1
Last split Date 15 Jun 2006
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 972.82
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 67.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 179.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 1.77%
Book value per share (mrq) 349.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
